hrp0094p2-166 | Diabetes and insulin | ESPE2021

How Does Continuous Glucose Monitoring Systems Effect Metabolic Control In Type 1 Diabetes: Single Center Experience

Arslan Emrullah , ER Eren , Demir Gunay , Isiklar Hafize , Atik Altinok Yasemin , Ozen Samim , Darcan Sukran , Goksen Damla ,

Introduction: Continuous Glucose Monitoring System (CGMS) takes place increasingly in the daily routines of diabetic patients. It has been shown that metabolic control improves when CGMS is used consistently. We aimed to show the effect of CGMS in patients using MDI therapyMaterials - Methods: All patients using multiple-dose insulin therapy at our center and continued their regular follow-up and using CGMS for at least three months were...

hrp0098p2-67 | Diabetes and Insulin | ESPE2024

Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy In Children <7 years with Type 1 Diabetes

Gül Uslu Nihal , Ozalp Kizilay Deniz , Demir Gunay , Atik Altinok Yasemin , Darcan Sukran , Ozen Samim , Goksen Damla

Objectives: Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMedâ„¢ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. The evaluation of the use of the Medtronic MinimedTM 780G in children under 7 years old was aim ed.Methods: Children under 7 years old with type 1 diabetes mellitus (T1D) using MiniMedâ„¢ 780G AHCL and a control g...